UBS’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$8.5M Buy
120,372
+88,900
+282% +$6.33M 0.01% 1576
2014
Q2
$2.18M Sell
31,472
-22,041
-41% -$1.55M ﹤0.01% 2786
2014
Q1
$4.02M Sell
53,513
-51,056
-49% -$3.82M ﹤0.01% 2077
2013
Q4
$7.34M Sell
104,569
-132,631
-56% -$8.66M 0.01% 1526
2013
Q3
$14.7M Buy
237,200
+185,800
+361% +$12M 0.02% 873
2013
Q2
$3.17M Buy
+51,400
New +$3.1M ﹤0.01% 2055

Other funds holding ESRX

UBS's ESRX Position: Q3 2014 in Review

UBS reduced its Express Scripts Holding Company (ESRX) stake by 6.3% in Q3 2014, selling an estimated $14.2M and leaving 2,942,077 shares worth $208M. The position accounts for 0.15% of the portfolio, ranked #147.

UBS first reported a position in ESRX in Q2 2013 and has held it in 6 quarters since. The position peaked at $238M in Q1 2014. 1,121 funds tracked by Wall St. Rank hold ESRX as of Q3 2014.

  • UBS held 2,942,077 shares of Express Scripts Holding Company worth $208M as of Q3 2014.
  • UBS sold 199,235 Express Scripts Holding Company shares in Q3 2014, an estimated $14.2M.
  • Express Scripts Holding Company made up 0.15% of UBS's portfolio in Q3 2014, its #147 holding.
  • UBS first reported a position in Express Scripts Holding Company in Q2 2013 and has held it in 6 quarters since.
  • UBS's Express Scripts Holding Company position peaked at $238M in Q1 2014.
  • 1,121 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.